COVID-19 Briefing Note – Product Liability Trends & Issues
Covid-19 has, within the first half 2020, penetrated virtually all aspects of modern life. Various aspects relating to the life-cycle – design, manufacture, supply and use – of several classes of product have been dramatically affected by its outbreak. The responses to it at an international, national and local level have been quite astonishing. This Briefing Note attempts to draw together a number of strands of the law relating to product liabilities and to summarise some of the crucial issues to consider against the backdrop of the pandemic. Embedded within the text are hyperlinks to a number of other resources produced by members of Chambers (or of general interest).
This Briefing Note identifies and explores issues arising from and related to the following:
- Novel medical devices, treatments and vaccine claims;
- Non-specialist manufacturer liabilities;
- Indemnity disputes, including government indemnities;
- The CMA; and
- Counterfeit / fraudulent products.